Christopher Lowe

2021

In 2021, Christopher Lowe earned a total compensation of $2.1M as Interim Chief Executive Officer, Chief Operating Officer and Chief Financial Officer and Treasurer at Cortexyme, a 77% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$196,652
Option Awards$1,478,000
Salary$445,000
Other$4,000
Total$2,123,652

Lowe received $1.5M in option awards, accounting for 70% of the total pay in 2021.

Lowe also received $196.7K in non-equity incentive plan, $445K in salary and $4K in other compensation.

Rankings

In 2021, Christopher Lowe's compensation ranked 5,827th out of 12,415 executives tracked by ExecPay. In other words, Lowe earned more than 53.1% of executives.

ClassificationRankingPercentile
All
5,827
out of 12,415
53rd
Division
Manufacturing
2,467
out of 5,508
55th
Major group
Chemicals And Allied Products
1,069
out of 2,378
55th
Industry group
Drugs
951
out of 2,099
55th
Industry
Biological Products, Except Diagnostic Substances
234
out of 449
48th

Pay ratio

Christopher Lowe's Pay$2,123,652
Median Employee's Pay$622,098
Pay Ratio

3

to 1

In 2021, the annual total compensation of Christopher Lowe was $2,123,652.

The annual total compensation of the median employee at Cortexyme was $622,098.

The ratio of Christopher Lowe's pay to the pay of median employee was therefore 3 to one.

Source: SEC filing on April 27, 2022.

Lowe's colleagues

We found four more compensation records of executives who worked with Christopher Lowe at Cortexyme in 2021.

2021

Casey Lynch

Cortexyme

Chief Executive Officer

2021

Michael Detke

Cortexyme

Chief Medical Officer

2021

Caryn McDowell

Cortexyme

Secretary

2021

Leslie Holsinger

Cortexyme

Executive Vice President of Preclinical Development

News

In-depth

You may also like